KISHIMOTO, TADAMITSU

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 3133
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1254
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
7361737 Mouse CXC chemokine receptorMay 22, 06Apr 22, 08[C07K]
6225051 Method of detecting solid cancer cells and tissue atypia and method of testing tissues for use in bone marrow transplantation and peripheral blood stem cell transplantationJun 26, 98May 01, 01[C12Q]
5866689 Monoclonal antibodies to GP130 proteinFeb 03, 97Feb 02, 99[C12N, C07K]
5844082 Human acute phase response factorNov 06, 97Dec 01, 98[C07K]
5719042 Nucleic acids encoding transcription factor APRF (acute phase response factor)Apr 04, 95Feb 17, 98[C07H, C12P, C12N]
5310550 Method of treating thrombocytopenia using human BCDF in combination with IL-3Jan 09, 92May 10, 94[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
7247424 Screening method for a substance having hypoglycemic activity by using STAT-induced inhibitor of STAT function-1ExpiredSep 11, 01Jul 24, 07[C12Q]
5215892 C/EBP2 gene and recombinant C/EBP2ExpiredOct 22, 90Jun 01, 93[A61K, C07H, C12P, C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.